D361-0366 Screening compound: 4-(3-methyl-6-oxo-1-{[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-4-yl)benzoic acid

D361-0366 Screening compound: 4-(3-methyl-6-oxo-1-{[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-4-yl)benzoic acid
D361-0366 Screening compound: 4-(3-methyl-6-oxo-1-{[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-4-yl)benzoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound D361-0366
4-(3-methyl-6-oxo-1-{[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-4-yl)benzoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D361-0366

Molecular Formula

C19H15N7O3 (C19 H15 N7 O3)

Compound Name

4-(3-methyl-6-oxo-1-{[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-4-yl)benzoic acid

IUPAC name

4-(3-methyl-6-oxo-1-{[124]triazolo[43-b]pyridazin-6-yl}-1H4H5H6H7H-pyrazolo[34-b]pyridin-4-yl)benzoic acid

SMILES

Cc(c(C(C1)c(cc2)ccc2C(O)=O)c2NC1=O)nn2-c(cc1)nn2c1nnc2

InChI

InChI=1S/C19H15N7O3/c1-10-17-13(11-2-4-12(5-3-11)19(28)29)8-16(27)21-18(17)26(23-10)15-7-6-14-22-20-9-25(14)24-15/h2-7,9,13H,8H2,1H3,(H,21,27)(H,28,29)/t13-/m0/s1

InChI Key

AUFJGBHAOBGCFU-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD14824663

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

389.37

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.248

Distribution Coefficient, logD

-1.724

Water Solubility, LogSw

-1.93

Polar Surface Area

100.044

Acid Dissociation Constant (pKa)

4.43

Base Dissociation Constant (pKb)

4.78

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

15.80

D361-0366 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D361-0366 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D361-0366?
Check Price and Availability of D361-0366, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D361-0366 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D361-0366
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D361-0366
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D361-0366 available by request